NeuroMetrix (NASDAQ:NURO) Now Covered by Analysts at initiated coverage on shares of NeuroMetrix (NASDAQ:NURO – Free Report) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the medical device company’s stock. NeuroMetrix Trading Down 6.4 % Shares of NURO stock opened at $3.97 on Thursday. The company’s 50-day moving average price is $4.65 and […]

Leave a Reply

Your email address will not be published.

Previous post Jack in the Box (NASDAQ:JACK) Price Target Cut to $77.00 by Analysts at UBS Group
Next post Lowers TELUS (NYSE:TU) to Sell